Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 870123, 7 pages
http://dx.doi.org/10.1155/2015/870123
Review Article

Bridging the Gap between Statistical and Biological Epistasis in Alzheimer’s Disease

Department of Biology, Brigham Young University, Provo, UT, USA

Received 6 March 2015; Accepted 5 May 2015

Academic Editor: Helen F. K. Chiu

Copyright © 2015 Mark T. W. Ebbert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. G. Ridge, M. T. W. Ebbert, and J. S. K. Kauwe, “Genetics of alzheimer's disease,” BioMed Research International, vol. 2013, Article ID 254954, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. C. Naj, G. Jun, G. W. Beecham et al., “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease,” Nature Genetics, vol. 43, no. 5, pp. 436–441, 2011. View at Publisher · View at Google Scholar
  3. P. Hollingworth, D. Harold, R. Sims et al., “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease,” Nature Genetics, vol. 43, no. 5, pp. 429–435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Williams and P. Amouyel, “Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease,” Nature Genetics, vol. 45, no. 12, pp. 1452–1458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Cruchaga, C. M. Karch, S. C. Jin et al., “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease,” Nature, vol. 505, pp. 550–554, 2014. View at Publisher · View at Google Scholar
  6. R. Guerreiro, A. Wojtas, J. Bras et al., “TREM2 variants in Alzheimer's disease,” The New England Journal of Medicine, vol. 368, no. 2, pp. 117–127, 2013. View at Publisher · View at Google Scholar
  7. T. Jonsson, H. Stefansson, S. Steinberg et al., “Variant of TREM2 associated with the risk of Alzheimer's disease,” The New England Journal of Medicine, vol. 368, pp. 107–116, 2013. View at Publisher · View at Google Scholar
  8. T. Jonsson, J. K. Atwal, S. Steinberg et al., “A mutation in APP protects against Alzheimer's disease and age-related cognitive decline,” Nature, vol. 488, no. 7409, pp. 96–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Ridge, S. Mukherjee, P. K. Crane, and J. S. K. Kauwe, “Alzheimer's disease: analyzing the missing heritability,” PLoS ONE, vol. 8, no. 11, Article ID e79771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Combarros, C. M. van Duijn, N. Hammond et al., “Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease,” Journal of Neuroinflammation, vol. 6, article 22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Bullock, C. Medway, M. Cortina-Borja et al., “Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease,” Neurobiology of Aging, vol. 34, no. 4, pp. 1309.e1–1309.e7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Combarros, M. Cortina-Borja, A. D. Smith, and D. J. Lehmann, “Epistasis in sporadic Alzheimer's disease,” Neurobiology of Aging, vol. 30, no. 9, pp. 1333–1349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. T. W. Ebbert, P. G. Ridge, A. R. Wilson et al., “Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions,” Biological Psychiatry, vol. 75, no. 9, pp. 732–737, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. Moore and S. M. Williams, “Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis,” BioEssays, vol. 27, no. 6, pp. 637–646, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Andrew, H. H. Nelson, K. T. Kelsey et al., “Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility,” Carcinogenesis, vol. 27, no. 5, pp. 1030–1037, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Briollais, Y. Wang, I. Rajendram et al., “Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario,” BMC Medicine, vol. 5, article 22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Chen, A. M. Kamat, M. Huang et al., “High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk,” Carcinogenesis, vol. 28, no. 10, pp. 2160–2165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. T. Tsai, J. J. Hwang, M. D. Ritchie et al., “Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction,” Atherosclerosis, vol. 195, no. 1, pp. 172–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. I. H. S. Chan, T. F. Leung, N. L. S. Tang et al., “Gene-gene interactions for asthma and plasma total IgE concentration in Chinese children,” Journal of Allergy and Clinical Immunology, vol. 117, no. 1, pp. 127–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-Y. Lee, J.-C. Kwon, and J.-J. Kim, “Multifactor dimensionality reduction (MDR) analysis to detect single nucleotide polymorphisms associated with a carcass trait in a Hanwoo population,” Asian-Australasian Journal of Animal Sciences, vol. 21, no. 6, pp. 784–788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Ritchie, D. W. Haas, A. A. Motsinger et al., “Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity,” Clinical Infectious Diseases, vol. 43, no. 6, pp. 779–782, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-W. Park, E.-S. Shin, J.-E. Lee et al., “Multilocus analysis of atopy in Korean children using multifactor-dimensionality reduction,” Thorax, vol. 62, no. 3, pp. 265–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Manuguerra, G. Matullo, F. Veglia et al., “Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions,” Carcinogenesis, vol. 28, no. 2, pp. 414–422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Julià, J. Moore, L. Miquel et al., “Identification of a two-loci epistatic interaction associated with susceptibility to rheumatoid arthritis through reverse engineering and multifactor dimensionality reduction,” Genomics, vol. 90, no. 1, pp. 6–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. T. L. Edwards, K. Lewis, D. R. Velez, S. Dudek, and M. D. Ritchie, “Exploring the performance of multifactor dimensionality reduction in large scale SNP studies and in the presence of genetic heterogeneity among epistatic disease models,” Human Heredity, vol. 67, no. 3, pp. 183–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. D. Ritchie, L. W. Hahn, N. Roodi et al., “Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer,” American Journal of Human Genetics, vol. 69, no. 1, pp. 138–147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. M. Cho, M. D. Ritchie, J. H. Moore et al., “Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus,” Diabetologia, vol. 47, no. 3, pp. 549–554, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. D. Ritchie, L. W. Hahn, and J. H. Moore, “Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity,” Genetic Epidemiology, vol. 24, no. 2, pp. 150–157, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. L. W. Hahn, M. D. Ritchie, and J. H. Moore, “Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions,” Bioinformatics, vol. 19, no. 3, pp. 376–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. C. S. Coffey, P. R. Hebert, M. D. Ritchie et al., “An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation,” BMC Bioinformatics, vol. 5, article 49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Y. Lee, Y. Chung, R. C. Elston, Y. Kim, and T. Park, “Log-linear model-based multifactor dimensionality reduction method to detect gene-gene interactions,” Bioinformatics, vol. 23, no. 19, pp. 2589–2595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Rodríguez-Rodríguez, I. Mateo, J. Infante et al., “Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk,” Brain Research, vol. 1280, pp. 166–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. K. J. H. Robson, D. J. Lehmann, V. L. C. Wimhurst et al., “Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease,” Journal of Medical Genetics, vol. 41, no. 4, pp. 261–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. S. K. Kauwe, S. Bertelsen, K. Mayo et al., “Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease,” The American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 153, no. 4, pp. 955–959, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Muendlein, C. H. Saely, T. Marte et al., “Synergistic effects of the apolipoprotein E ε3/ε2/ε4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3—482 C > T polymorphisms on their association with coronary artery disease,” Atherosclerosis, vol. 199, no. 1, pp. 179–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Polito, P. G. Kehoe, A. Davin et al., “The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts,” Alzheimer's and Dementia, vol. 9, no. 4, pp. 392–399, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Hiltunen, A. Mannermaa, S. Helisalmi et al., “Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients,” Neuroscience Letters, vol. 250, no. 1, pp. 69–71, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Licastro, M. Chiappelli, L. M. E. Grimaldi et al., “A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease,” Neurobiology of Aging, vol. 26, no. 4, pp. 449–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Talbot, H. Houlden, N. Craddock et al., “Polymorphism in AACT gene may lower age of onset of Alzheimer's disease,” NeuroReport, vol. 7, no. 2, pp. 534–536, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. O. Combarros, M. García-Román, A. Fontalba et al., “Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 15, no. 3, pp. 151–154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Kamino, K. Nagasaka, M. Imagawa et al., “Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population,” Biochemical and Biophysical Research Communications, vol. 273, no. 1, pp. 192–196, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. J.-M. Kim, R. Stewart, I.-S. Shin, J.-S. Jung, and J.-S. Yoon, “Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population,” Neurobiology of Aging, vol. 25, no. 3, pp. 295–301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Kang, W. Yue, J. Zhang, Y. Cui, Y. Zuo, and D. Zhang, “An entropy-based approach for testing genetic epistasis underlying complex diseases,” Journal of Theoretical Biology, vol. 250, no. 2, pp. 362–374, 2008. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  44. X. Wan, C. Yang, Q. Yang et al., “BOOST: a fast approach to detecting gene-gene interactions in genome-wide case-control studies,” American Journal of Human Genetics, vol. 87, no. 3, pp. 325–340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. H. He, W. S. Oetting, M. J. Brott, and S. Basu, “Pair-wise multifactor dimensionality reduction method to detect gene-gene interactions in a case-control study,” Human Heredity, vol. 69, no. 1, pp. 60–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Y. Park and T. Hastie, “Penalized logistic regression for detecting gene interactions,” Biostatistics, vol. 9, no. 1, pp. 30–50, 2008. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  47. S. K. Musani, D. Shriner, N. Liu et al., “Detection of gene x gene interactions in genome-wide association studies of human population data,” Human Heredity, vol. 63, no. 2, pp. 67–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. D. R. Velez, B. C. White, A. A. Motsinger et al., “A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction,” Genetic Epidemiology, vol. 31, no. 4, pp. 306–315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. J. H. Moore, “Computational analysis of gene-gene interactions using multifactor dimensionality reduction,” Expert Review of Molecular Diagnostics, vol. 4, no. 6, pp. 795–803, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Cattaert, M. L. Calle, S. M. Dudek et al., “Model-based multifactor dimensionality reduction for detecting epistasis in case-control data in the presence of noise,” Annals of Human Genetics, vol. 75, no. 1, pp. 78–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Namkung, R. C. Elston, J.-M. Yang, and T. Park, “Identification of gene-gene interactions in the presence of missing data using the multifactor dimensionality reduction method,” Genetic Epidemiology, vol. 33, no. 7, pp. 646–656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. J. H. Moore, J. C. Gilbert, C.-T. Tsai et al., “A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility,” Journal of Theoretical Biology, vol. 241, no. 2, pp. 252–261, 2006. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  53. G. P. Page, V. George, R. C. Go, P. Z. Page, and D. B. Allison, ““Are we there yet?”: deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits,” American Journal of Human Genetics, vol. 73, no. 4, pp. 711–719, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. C. G. Howard and P. Bock, “Using a hierarchical approach to avoid over-fitting in early vision,” in Proceedings of the 12th IAPR International Conference on Pattern Recognition, Volume 1—Conference A: Computer Vision amp; Image Processing, pp. 826–829, 1994.
  55. P. Gorroochurn, S. E. Hodge, G. A. Heiman, M. Durner, and D. A. Greenberg, “Non-replication of association studies: ‘Pseudo-failures’ to replicate?” Genetics in Medicine, vol. 9, no. 6, pp. 325–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. J. Wade, “Epistasis, complex traits, and mapping genes,” Genetica, vol. 112-113, pp. 59–69, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. J. R. Connor, S. L. Menzies, S. M. St. Martin, and E. J. Mufson, “A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains,” Journal of Neuroscience Research, vol. 31, no. 1, pp. 75–83, 1992. View at Publisher · View at Google Scholar · View at Scopus
  58. D. A. Loeffler, J. R. Connor, P. L. Juneau et al., “Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions,” Journal of Neurochemistry, vol. 65, no. 2, pp. 710–724, 1995. View at Google Scholar · View at Scopus
  59. M. A. Smith, P. L. R. Harris, L. M. Sayre, and G. Perry, “Iron accumulation in Alzheimer disease is a source of redox-generated free radicals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9866–9868, 1997. View at Publisher · View at Google Scholar · View at Scopus
  60. J. N. Feder, D. M. Penny, A. Irrinki et al., “The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 4, pp. 1472–1477, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Townsend and H. Drakesmith, “Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload,” The Lancet, vol. 359, no. 9308, pp. 786–790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Giunta, R. Galeazzi, M. B. Valli, E. H. Corder, and L. Galeazzi, “Transferrin neutralization of amyloid beta 25-35 cytotoxicity,” Clinica Chimica Acta, vol. 350, no. 1-2, pp. 129–136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. D. J. Lehmann, J. Williams, J. Mcbroom, and A. D. Smith, “Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups,” Neuroscience, vol. 108, no. 4, pp. 541–554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Infante, C. Sanz, J. L. Fernández-Luna, J. Llorca, J. Berciano, and O. Combarros, “Gene-gene interaction between interleukin-6 and interleukin-10 reduces AD risk,” Neurology, vol. 63, no. 6, pp. 1135–1136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. E. J. Remarque, E. L. E. M. Bollen, A. W. E. Weverling-Rijnsburger, J. C. Laterveer, G. J. Blauw, and R. G. J. Westendorp, “Patients with Alzheimer's disease display a pro-inflammatory phenotype,” Experimental Gerontology, vol. 36, no. 1, pp. 171–176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. E. S. Gusareva, M. M. Carrasquillo, C. Bellenguez et al., “Genome-wide association interaction analysis for Alzheimer's disease,” Neurobiology of Aging, vol. 35, no. 11, pp. 2436–2443, 2014. View at Publisher · View at Google Scholar
  67. R. C. Dickson, “Thematic review series: sphingolipids. New insights into sphingolipid metabolism and function in budding yeast,” Journal of Lipid Research, vol. 49, no. 5, pp. 909–921, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Berchtold, M. Piccolis, N. Chiaruttini et al., “Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis,” Nature Cell Biology, vol. 14, no. 5, pp. 542–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Pierce, N. Podlutskaya, J. J. Halloran et al., “Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease,” Journal of Neurochemistry, vol. 124, no. 6, pp. 880–893, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. B. F. J. Verhaaren, M. W. Vernooij, P. J. Koudstaal et al., “Alzheimer's disease genes and cognition in the nondemented general population,” Biological Psychiatry, vol. 73, no. 5, pp. 429–434, 2013. View at Publisher · View at Google Scholar · View at Scopus